Warning Letter Wednesday® Posts

A weekly exploration of FDA warning letters and enforcement trends


August 21, 2024
Takeaway -

Even lower risk statements can trigger NAD scrutiny

August 14, 2024
Takeaway -

Copackers & distributors must comply with GMPs

August 7, 2024
Takeaway -

Flu & virus claims are enough for regulatory action

July 31, 2024
Takeaway -

Specifications continue to be cited

July 17, 2024
Takeaway -

Unsafe products marketed to children are deceptive

July 10, 2024
Takeaway -

Food safety plans should be comprehensive

July 3, 2024
Takeaway -

Review of NAD case

June 26, 2024
Takeaway -

Blogs can be considered marketing

June 19, 2024
Takeaway -

Email newsletters are marketing

June 12, 2024
Takeaway -

Reduce litigation by following labeling rules

June 5, 2024
Takeaway -

Sponsored children’s content has increased disclosure requirements

May 22, 2024
Takeaway -

Study design must be correct